Today, Urgo Medical innovations are available to health professionals in 35 countries with a leadership in compression, and second larger player in wound care in Europe. Urgo Medical believes in evidence based medicine to validate strategic therapeutics through RCTs, like recently with Explorer Study on DFU patients, published in Lancet Diabetes & Endocrinology.
In keeping with its field of expertise in healing, Urgo Medical today devotes attention to scar management, the end result of wound healing. UrgoTouch is the 1st automated portable laser for use in the operating theatre to improve scar outcome for all phototypes (I to VI). The SLASH Study, doubled blind RCT published in the Aesthetic Plastic Surgery Journal (level 1) has proved its efficacy.
Contact:
Erwan Blanchard, Marketing Manager
+33(0) 1 85 65 24 58 - e.blanchard@fr.urgo.com
Address:
Laboratoires Urgo, 15 avenue d’Iena, 75116 Paris